Omalizumab 150mg Injection

Product Introduction

Omalizumab 150mg is an anti-IgE biologic used as add-on treatment for appropriate allergic asthma and chronic spontaneous urticaria. It reduces allergic activation rather than treating an acute attack.

How to use

Administer by subcutaneous injection at the condition-specific interval. Asthma dosing uses body weight and pretreatment IgE; urticaria dosing follows a different approach. Initial administration and observation address anaphylaxis risk.

How it works

Omalizumab binds free IgE, reducing its interaction with high-affinity receptors on mast cells and basophils.

Side effects

Injection-site discomfort, headache, joint pain or fatigue can occur. Anaphylaxis can occur after early or later doses and requires emergency treatment.

Important information

Continue the existing asthma controller plan unless it is deliberately adjusted. This medicine is not a rescue inhaler or emergency adrenaline. Previous severe allergy and possible parasitic infection are relevant.